Aclarion (ACON)
(Delayed Data from NSDQ)
$9.40 USD
+1.20 (14.63%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $9.39 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ACON 9.40 +1.20(14.63%)
Will ACON be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ACON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACON
AMN Healthcare Services (AMN) Tops Q2 Earnings and Revenue Estimates
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
ACON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aclarion (ACON) Upgraded to Buy: Here's What You Should Know
Agilon Health (AGL) Reports Q3 Loss, Lags Revenue Estimates
Other News for ACON
Is ACON likely to continue higher? Reversal New Highs Setup shows up after soaring 7.52%
12 Health Care Stocks Moving In Friday's Pre-Market Session
Ascendiant Sticks to Their Buy Rating for Aclarion, Inc. (ACON)
ACON Stock: Analyst Boosts Price Target While Maintaining Buy Rating | ACON Stock News
Upper Bollinger Band Walk appears for ACON after 0.57% move